Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1991 2
1992 6
1993 8
1994 5
1995 10
1996 6
1997 7
1998 5
1999 7
2000 7
2002 7
2003 3
2004 3
2005 2
2006 1
2007 1
2008 2
2009 4
2010 5
2011 5
2012 4
2013 4
2014 6
2015 8
2016 7
2017 6
2018 10
2019 11
2020 7
2021 5
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma.
Grewal RK, Chetty M, Abayomi EA, Tomuleasa C, Fromm JR. Grewal RK, et al. Among authors: fromm jr. Cytometry B Clin Cytom. 2019 Mar;96(2):116-127. doi: 10.1002/cyto.b.21724. Epub 2018 Oct 22. Cytometry B Clin Cytom. 2019. PMID: 30350336 Free article. Review.
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, Paessler M, June CH, Luning Prak ET, Bhoj VG, Grupp SA, Maude SL, Rheingold SR. Pillai V, et al. Among authors: fromm jr. Blood Adv. 2019 Nov 26;3(22):3539-3549. doi: 10.1182/bloodadvances.2019000692. Blood Adv. 2019. PMID: 31738832 Free PMC article.
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Lynch RC, Cassaday RD, Smith SD, Fromm JR, Cowan AJ, Warren EH, Shadman MS, Shustov A, Till BG, Ujjani CS, Libby EN 3rd, Philip M, Coye H, Martino CN, Bhark SL, Morris K, Rasmussen H, Behnia S, Voutsinas J, Gopal AK. Lynch RC, et al. Among authors: fromm jr. Lancet Haematol. 2021 Aug;8(8):e562-e571. doi: 10.1016/S2352-3026(21)00170-8. Lancet Haematol. 2021. PMID: 34329577 Free PMC article. Clinical Trial.
Blood substitutes.
Fromm RE Jr. Fromm RE Jr. Crit Care Med. 2000 Jun;28(6):2150-1. doi: 10.1097/00003246-200006000-00091. Crit Care Med. 2000. PMID: 10890689 No abstract available.
Critical care transport.
Fromm RE Jr, Varon J. Fromm RE Jr, et al. Crit Care Clin. 2000 Oct;16(4):695-705. doi: 10.1016/s0749-0704(05)70141-x. Crit Care Clin. 2000. PMID: 11070812 Review.
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Rodriguez CP, Wu QV, Voutsinas J, Fromm JR, Jiang X, Pillarisetty VG, Lee SM, Santana-Davila R, Goulart B, Baik CS, Chow LQM, Eaton K, Martins R. Rodriguez CP, et al. Among authors: fromm jr. Clin Cancer Res. 2020 Feb 15;26(4):837-845. doi: 10.1158/1078-0432.CCR-19-2214. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796519 Clinical Trial.
Emergency medicine cyberspace.
Fromm RE Jr, Varon J, Sternbach GL. Fromm RE Jr, et al. J Emerg Med. 1996 Jan-Feb;14(1):91-2. doi: 10.1016/0736-4679(96)88456-3. J Emerg Med. 1996. PMID: 8655946 No abstract available.
The humane societies.
Sternbach GL, Varon J, Fromm R Jr, Baskett PJ. Sternbach GL, et al. Among authors: fromm r jr. Resuscitation. 2000 Jul;45(2):71-5. doi: 10.1016/s0300-9572(00)00201-x. Resuscitation. 2000. PMID: 10950313 No abstract available.
151 results